| Ratio of drug level in brain to plasma in rat at 0.3 mg/kg - BioAssay Summary A series of fused bicyclic heterocycles was identified as potent and selective 5-HT(2A) receptor antagonists. Optimization of the series resulted in compounds that had improved PK properties, favorable CNS partitioning, good pharmacokinetic properties, and significant improvements on deep sleep (delta power) and sleep consolidation. ..more |
_ | |
||||||||||||||||||||||||||||||||||||||||||||||||
Tested Compound: Description: Title: Identification of fused bicyclic heterocycles as potent and selective 5-HT(2A) receptor antagonists for the treatment of insomnia. Abstract: A series of fused bicyclic heterocycles was identified as potent and selective 5-HT(2A) receptor antagonists. Optimization of the series resulted in compounds that had improved PK properties, favorable CNS partitioning, good pharmacokinetic properties, and significant improvements on deep sleep (delta power) and sleep consolidation. (PMID: 22325948) Comment Putative Target: ChEMBL Target ID: 22226 Target Type: UNCHECKED Pref Name: Unchecked Confidence: Default value - Target unknown or has yet to be assigned Relationship Type: Default value - Target has yet to be curated Categorized Comment ChEMBL Assay Type: ADMET ChEMBL Assay Data Source: Scientific Literature Result Definitions
Data Table (Concise)
PageFrom: |
||||||||||||||||||||||||||||||||||||||||||||||||||